CD96 Antibodies

Santa Cruz Biotechnology features a diverse variety of CD96 Antibodies for research focused on understanding immune regulation and cell adhesion mechanisms. CD96 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD96, also known as Tactile, is a member of the immunoglobulin superfamily with significant functions in immune system regulation. CD96 is predominantly expressed on activated T cells and natural killer (NK) cells, where it modulates immune responses and facilitates cell-cell interactions. Research involving CD96 continues to reveal important insights into cancer immunotherapy approaches and autoimmune disease mechanisms. Scientists investigating CD96 can utilize specific conjugates, including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC), for enhanced detection and analysis. Ongoing studies of CD96 expression patterns and functional characteristics are expanding our understanding of immune system dynamics. Current research directions include exploring CD96's role in tumor surveillance and potential therapeutic applications. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific knowledge of CD96 and its implications in human health and disease.